CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 178 filers reported holding CRISPR THERAPEUTICS AG in Q1 2019. The put-call ratio across all filers is 1.73 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $953,000 | +85.4% | 15,649 | +24.7% | 0.01% | +50.0% |
| Q3 2019 | $514,000 | -2.5% | 12,545 | +12.5% | 0.00% | 0.0% |
| Q2 2019 | $527,000 | +33.4% | 11,151 | +1.1% | 0.00% | +33.3% |
| Q1 2019 | $395,000 | +33.0% | 11,034 | +6.0% | 0.00% | 0.0% |
| Q4 2018 | $297,000 | -21.8% | 10,406 | +21.7% | 0.00% | 0.0% |
| Q3 2018 | $380,000 | +104.3% | 8,551 | +110.9% | 0.00% | +50.0% |
| Q2 2018 | $186,000 | 0.0% | 4,054 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $186,000 | +745.5% | 4,054 | +334.0% | 0.00% | – |
| Q4 2017 | $22,000 | +100.0% | 934 | +47.3% | 0.00% | – |
| Q3 2017 | $11,000 | +450.0% | 634 | +534.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |